Jacob Hurst
Jacob Hurst
Etcembly Ltd
Verified email at - Homepage
Cited by
Cited by
HIV-1 DNA predicts disease progression and post-treatment virological control
JP Williams, J Hurst, W Stöhr, N Robinson, H Brown, M Fisher, S Kinloch, ...
elife 3, e03821, 2014
Type 1 Autoimmune Pancreatitis and IgG4-Related Sclerosing Cholangitis Is Associated With Extrapancreatic Organ Failure, Malignancy, and Mortality in a Prospective UK Cohort
GJMWEBBS Matthew T Huggett, E L Culver, M Kumar, J M Hurst, M Rodriguez ...
American Journal of Gastroenterology, 1675–1683, 2014
Clustering of Pseudomonas aeruginosa transcriptomes from planktonic cultures, developing and mature biofilms reveals distinct expression profiles
RD Waite, A Paccanaro, A Papakonstantinopoulou, JM Hurst, M Saqi, ...
BMC genomics 7 (1), 1-14, 2006
Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
J Hurst, M Hoffmann, M Pace, JP Williams, J Thornhill, E Hamlyn, ...
Nature communications 6 (1), 1-9, 2015
Low copy target detection by Droplet Digital PCR through application of a novel open access bioinformatic pipeline,‘definetherain’
M Jones, J Williams, K Gärtner, R Phillips, J Hurst, J Frater
Journal of virological methods 202, 46-53, 2014
Exhaustion of activated CD8 T cells predicts disease progression in primary HIV-1 infection
M Hoffmann, N Pantazis, GE Martin, S Hickling, J Hurst, J Meyerowitz, ...
PLoS pathogens 12 (7), e1005661, 2016
Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection
M Muenchhoff, E Adland, O Karimanzira, C Crowther, M Pace, A Csala, ...
Science translational medicine 8 (358), 358ra125-358ra125, 2016
abYsis: integrated antibody sequence and structure—management, analysis, and prediction
MB Swindells, CT Porter, M Couch, J Hurst, KR Abhinandan, JH Nielsen, ...
Journal of molecular biology 429 (3), 356-364, 2017
ZCS redux
L Bull, J Hurst
Evolutionary Computation 10 (2), 185-205, 2002
Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection
K Fitzmaurice, J Hurst, M Dring, A Rauch, PJ McLaren, HF Günthard, ...
Gut 64 (5), 813-819, 2015
Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic MelanomaAntitumor Responses …
MR Middleton, C McAlpine, VK Woodcock, P Corrie, JR Infante, ...
Clinical Cancer Research 26 (22), 5869-5878, 2020
The SAAPdb web resource: A large‐scale structural analysis of mutant proteins
JM Hurst, LEM McMillan, CT Porter, J Allen, A Fakorede, ACR Martin
Human mutation 30 (4), 616-624, 2009
Discordant impact of HLA on viral replicative capacity and disease progression in pediatric and adult HIV infection
E Adland, P Paioni, C Thobakgale, L Laker, L Mori, M Muenchhoff, ...
PLoS pathogens 11 (6), e1004954, 2015
A neural learning classifier system with self-adaptive constructivism for mobile robot control
J Hurst, L Bull
Artificial Life 12 (3), 353-380, 2006
Polyfunctional response by ImmTAC (IMCgp100) redirected CD8+ and CD4+ T cells
C Boudousquie, G Bossi, JM Hurst, KA Rygiel, BK Jakobsen, NJ Hassan
Immunology 152 (3), 425-438, 2017
TCS learning classifier system controller on a real robot
J Hurst, L Bull, C Melhuish
International Conference on Parallel Problem Solving from Nature, 588-597, 2002
Self-adaptive mutation in classifier system controllers
L Bull, J Hurst, A Tomlinson
From Animals to Animats 6, 460-467, 2000
Structured observations reveal slow HIV-1 CTL escape
HE Roberts, J Hurst, N Robinson, H Brown, P Flanagan, L Vass, S Fidler, ...
PLoS genetics 11 (2), e1004914, 2015
Compensated pathogenic deviations: analysis of structural effects
A Barešić, LEM Hopcroft, HH Rogers, JM Hurst, ACR Martin
Journal of molecular biology 396 (1), 19-30, 2010
Sex differences in antiretroviral therapy initiation in pediatric HIV infection
M Mori, E Adland, P Paioni, A Swordy, L Mori, L Laker, M Muenchhoff, ...
PloS one 10 (7), e0131591, 2015
The system can't perform the operation now. Try again later.
Articles 1–20